The demand for dermatology services is growing and expected to exceed $13 billion by 2017. This unprecedented growth in the practice of dermatology offersopportunities for private equity and other investors.

Counsel for dermatologists, dermatology practices, and investors must understand the composition of the market and the different deal structures available in order to determine which structure is most appropriate for the transaction in question. Counsel must also consider corporate practice of medicine and fee splitting, HIPAA compliance, Stark compliance, and noncompete enforceability in assessing whether to go forward with the sale, merger, acquisition or purchase of a practice.

The panel will provide guidance to counsel representing dermatology practices and investors when evaluating the various transaction structures for buying or selling a practice, conducting due diligence, and meeting regulatory compliance requirements. They will also offer best practices for executing dermatology practice deal transactions.

After the presentation there will be a live question and answer session with participants.